Infanrix Polio

Diphtheria and tetanus toxoids and acellular pertussis adsorbed, combined with inactivated poliovirus vaccine, the active ingredient in Infanrix Polio, is a prophylactic vaccine presented as an injectable solution for intramuscular use. It is indicated for the prevention of diphtheria, tetanus, pertussis (whooping cough) and poliomyelitis in infants and young children.

GNH USA supplies Infanrix Polio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infanrix Polio is a combination vaccine that targets bacterial toxins and viral particles to provide active immunity against several childhood diseases. - Diphtheria: induces protective antibodies that neutralize diphtheria toxin. - Tetanus: stimulates immunity that prevents tetanus toxin effects. - Pertussis: generates antibodies against pertussis antigens, reducing whooping cough incidence. - Poliomyelitis: elicits immunity to inactivated poliovirus types 1, 2 and 3, preventing paralytic disease.

Common Side Effects: - Pain at the injection site: mild to moderate discomfort. - Redness or swelling: localized inflammatory reaction. - Fever: low‑grade temperature rise within 24‑48 hours. - Irritability or crying: especially in infants. - Loss of appetite: temporary reduction in feeding. - Headache: mild, self‑limiting.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: rare neurologic events post‑vaccination. - High fever (>40 °C): may indicate systemic response. - Prolonged crying episodes: could signal discomfort or rare neurologic involvement. - Hypotonic‑hyporesponsive episode: transient loss of muscle tone. - Encephalopathy: extremely rare central nervous system complication.

Before administration, consider the following precautions: - Allergy screening: avoid in individuals with known hypersensitivity to any vaccine component. - Immediate observation: monitor the recipient for at least 15 minutes for acute reactions. - Acute illness: postpone vaccination if the child has a moderate or severe febrile illness. - Age limits: follow the recommended immunisation schedule; do not give to infants younger than the approved age. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Vaccines can interact with other agents that modify immune responses. Major Interactions (Avoid): - Live attenuated vaccines given concurrently: may reduce the immune response to one or both products. - Immunoglobulin therapy administered within two weeks: can neutralise vaccine antigens. Moderate Interactions (Monitor Closely): - Prophylactic antipyretics (acetaminophen, ibuprofen): may blunt antibody production if given routinely. - Corticosteroids or other immunosuppressants: may diminish vaccine efficacy. - Pregnancy: limited safety data; use only when benefits outweigh potential risks.